Abingdon Health (LON:ABDX) Stock Price Down 3.1%

Abingdon Health Plc (LON:ABDX) dropped 3.1% on Friday . The company traded as low as GBX 9.69 ($0.13) and last traded at GBX 9.69 ($0.13). Approximately 82,841 shares were traded during mid-day trading, a decline of 65% from the average daily volume of 240,078 shares. The stock had previously closed at GBX 10 ($0.13).

Abingdon Health Price Performance

The business’s 50 day moving average is GBX 10.18 and its two-hundred day moving average is GBX 9.98. The company has a debt-to-equity ratio of 55.57, a current ratio of 1.79 and a quick ratio of 1.96. The firm has a market capitalization of £18.36 million, a PE ratio of -969.00 and a beta of 0.14.

Abingdon Health Company Profile

Abingdon Health Plc engages in the development, manufacture, and distribution of diagnostic devices in the United Kingdom, the United States, Canada, Europe, and internationally. The company provides Abingdon Simply Test, a range of self-tests in the field of fertility, health and well-being, infectious diseases, and drug testing; PCRD and PCRD FLEX, are nucleic acid lateral flow tests, which are used for rapid readouts post isothermal amplification; and 2019-nCoV Antigen Test, a rapid lateral flow test for the qualitative detection of antigens to SARS-CoV-2, as well as plant health tests; and nucleic acid lateral flow immunoassays.